Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications [Seguridad de los anticuerpos monoclonales anti-CGRP en pacientes con migraña durante la pandemia de COVID-19: implicaciones actuales y futuras]
- Caronna, E. et al
- ART-2021-124265
Main fichier(s):
 texto_completo
|
|||||||
| version 1 |
| ||||||
